Southside Veterinary Center Moultrie, GA, United States
Chronic degenerative (myxomatous) valvular disease is the most important cause of heart disease and cardiac failure in dogs. This session focuses on staging and therapy for the different stages of preclinical and clinical valvular heart disease in dogs. Appropriate use of cardiac drugs is emphasized.
Outline current approaches to the diagnosis or acquired valvular heart disease in the dog.
Outline the ACVIM staging of acquired (myxomatous) valvular heart disease (MMVD) in the dog.
Explain the diagnostic imaging findings (radiography, echocardiography) typical of mild to advanced MMVD.
Describe the value and challenges of using blood natriuretic peptide (NT-proBNP) concentrations in the assessment of MMVD.
Summarize the preclinical therapy of MMVD and the criteria that justify starting treatment.
Outline an approach for treating acute left-sided heart failure in the dog with MMVD.
Outline the chronic, at-home management of congestive heart failure in the dog.